Recovery From Hemoglobin Of 2g/Dl Without Prbc Transfusion: A Lesson Learned From a Jehovah’s Witness With Cold Agglutinin Disease

Blood ◽  
2013 ◽  
Vol 122 (21) ◽  
pp. 4657-4657
Author(s):  
Pouyan Gohari ◽  
Abhinav B. Chandra ◽  
Richard Slatkin ◽  
Jay S. Lipshitz

Supportive management of critically ill patients with anemia often involves packed red blood cell transfusion. Jehovah’s Witness’ refusal of blood products because of their religious beliefs can render these situations challenging. Successful adaptation of medical management in Jehovah’s Witness’ with severe anemia provides physicians with a distinct opportunity to question common transfusion practices and learn about anemia. We present a case of a 43 year-old Jehovahs Witness who presented with autoimmune hemolytic anemia – cold agglutinin disease. His hemoglobin nadired at 2g/dL. The patient was successfully managed to recovery with corticosteroids, rituximab, folic acid and an erythropoeitin stimulating agent. To our knowledge this is the lowest Hgb that a patient with life threatening cold agglutinin disease survived without the use of any blood product transfusion. Such cases afford a deeper appreciation of the body's ability to adapt to and recover from anemia without the use of exogenous blood. Disclosures: No relevant conflicts of interest to declare.

2018 ◽  
Vol 11 (1) ◽  
pp. e226497 ◽  
Author(s):  
Nivedita Arora ◽  
Arjun Gupta ◽  
Hsiao C Li ◽  
Navid Sadeghi

We present a 21-year-old woman diagnosed with Philadelphia (Ph) chromosome-like CD20 positive B-cell acute lymphoblastic leukaemia (ALL). She was a Jehovah’s Witness (JW) and declined all blood product transfusion support. She was initiated on the CALGB 10403 chemotherapy protocol for her ALL. She received darbepoetin alfa and romiplostim as supportive therapies for her disease/chemotherapy-associated anaemia and thrombocytopaenia. A complete remission was achieved with negative minimal residual disease and she remains in remission 18 months after diagnosis. This case report describes the successful treatment of an adult JW with Ph-like CD20 +B cell ALL, in the absence of blood product transfusions, using growth factor support.


2018 ◽  
Vol 34 (2) ◽  
pp. 165-170
Author(s):  
Patrick Kishi ◽  
Eric vanSonnenberg ◽  
Misa Stroker

Blood transfusions in anemic patients frequently are used for critically ill patients as a life-saving therapeutic maneuver. Jehovah’s Witness (JW) patients typically refuse blood transfusions due to religious beliefs. Numerous clinical reports, in a wide spectrum of medical specialties, have shown no greater morbidity or mortality in JW patients or others who refused transfusions compared to those patients who accept transfusions. We report our experience with two JW patients who presented with severe anemia and life-threatening pancreatitis. Despite undergoing percutaneous drainages by interventional radiology (IR) for complex pancreatic collections (and other IR drainages), neither patient suffered any adverse effect from the IR procedures, even though they refused blood transfusions. Our experience suggests that IR procedures also may be successful with this more limited blood product protocol.


2005 ◽  
Vol 94 (4) ◽  
pp. 442-444 ◽  
Author(s):  
G. Scha¨lte ◽  
H. Janz ◽  
J. Busse ◽  
V. Jovanovic ◽  
R. Rossaint ◽  
...  

2010 ◽  
Vol 25 (1) ◽  
pp. 52
Author(s):  
Ji Hyeon Lee ◽  
So Ron Choi ◽  
Young Jhoon Chin ◽  
Soo Il Lee ◽  
Chan Jong Chung ◽  
...  

2005 ◽  
Vol 52 (4) ◽  
pp. 369-373 ◽  
Author(s):  
Marcella J. Lanzinger ◽  
Steven E. Hill ◽  
Laura E. Niklason ◽  
Michael Shannon

Sign in / Sign up

Export Citation Format

Share Document